Volume 34, 15 August 2003 08/2003
 
  SPOT ON

Manipulated data in the STOP-NIDDM trial on acarbose
COMET: Carvedilol vs metoprolol in heart failure

 
  NEW ON THE MARKET
 

Transdermal contraception with EVRA

 
  BEWARE! MISINFORMATION
 

Atorvastatin (SORTIS) and the ASCOT trial

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Candesartan (e.g. ATACAND) for prophylaxis of migraine headaches?
Pfizer argues against generic preparations of gabapentin
Buprenorphine TDS compatible with opioids?
VIANI promotional material as hazardous waste

 
  IN BRIEF
 

Expired drugs ineffective or dangerous?
Migraine: Ergotamine now 700% more expensive
Raloxifene (e.g. EVISTA) lowering levothyroxine levels
Warning sheet for the wallet: Antimalarial mefloquine (LARIAM) and neuropsychic symptoms

 
  CURRENT ADR NETWORK REPORT
 

Renal failure due to COX-2 inhibitors
Hypersensitivity reaction triggered by ezetimibe (EZETROL)

 
  SIDE EFFECTS
 

Antimalarial MALARONE: Suicidality and severe skin reactions
Fatalities under growth hormone (GENOTROPIN)
Hormone replacement therapy and breast cancer mortality

 
© arznei-telegramm 08/2003